|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-4-24
|
|
pubmed:abstractText |
To evaluate the clinical significance of antineutrophil cytoplasmic antibodies (ANCA) in patients with rheumatoid arthritis (RA), and especially in those with clinically suspected or histologically proven nephropathy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
710-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9125254-Adolescent,
pubmed-meshheading:9125254-Adult,
pubmed-meshheading:9125254-Aged,
pubmed-meshheading:9125254-Aged, 80 and over,
pubmed-meshheading:9125254-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:9125254-Arthritis, Rheumatoid,
pubmed-meshheading:9125254-Autoantigens,
pubmed-meshheading:9125254-Biological Markers,
pubmed-meshheading:9125254-Child,
pubmed-meshheading:9125254-Female,
pubmed-meshheading:9125254-Fluorescent Antibody Technique,
pubmed-meshheading:9125254-Glomerulonephritis,
pubmed-meshheading:9125254-Humans,
pubmed-meshheading:9125254-Immunoenzyme Techniques,
pubmed-meshheading:9125254-Male,
pubmed-meshheading:9125254-Middle Aged
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy.
|
|
pubmed:affiliation |
Department of Clinical Microbiology, Tampere University Hospital, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
